Alzheimer's disease is highly heterogeneous, making it difficult for any single preclinical model to capture the full complexity of human disease biology and therapeutic response.

In this episode, Dr. Janell Richardson explores emerging approaches to Alzheimer's disease modeling and discusses how advanced preclinical platforms can help researchers investigate genotype-dependent differences and improve translational relevance.

Learn more at taconic.com/neuro-videos.